合成的rEg.P29诱导小鼠对埃奇诺菌颗粒菌的保护性免疫反应
Yongxue Lv1,2, Jing Tang1,2, Tao Li3
1School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
Vaccines
|April 23, 2025
概括
一种新型重组蛋白P29 (rEg.P29) 类疫苗有效地降低了小鼠中的 Echinococcus granulosus 囊负担. 这种疫苗策略表明,它有望预防动物和人类的寄生虫感染.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 疫苗开发 疫苗开发
背景情况:
- Echinococcus granulosus感染对畜牧业和人类健康构成重大威胁,其影响往往被低估.
- 疫苗接种是一个可行的策略,可以预防埃奇诺科克细粒菌感染.
研究的目的:
- 为了研究由 Echinococcus granulosus (rEg.P29) 疫苗的复合蛋白 P29 诱导的免疫保护作用.
- 评估基于rEg.P29的疫苗在减少寄生性囊负担方面的有效性.
主要方法:
- 流细胞测量用于分析感染小鼠脏和周围血液中的T细胞群 (CD4+,CD8+,Treg,CD8+CD107a+).
- 通过记忆T细胞测量细胞因子分泌 (IFN-γ,IL-2,TNF-α) 并分析B细胞群 (血细胞,记忆B细胞) 和特定抗体度.
- 在实验小组中评估寄生性囊负担.
主要成果:
- 用rEg.P29接种疫苗,特别是使用CpG辅助剂,显著提高了IFN-γ,IL-2,TNF-α和疫苗特异性抗体的水平.
- 在接种疫苗的组中观察到血细胞和特定记忆B细胞 (IgG +,IgA +) 的增加.
- 与对照组相比,与rEg.P29 + CpG接种疫苗的小鼠实现了 Echinococcus granulosus 囊负担的显著降低.
结论:
- 针对 rEg.P29 的合成类疫苗在抑制 Echinococcus granulosus 囊方面表现出显著的有效性.
- 这些发现支持基于rEg.P29的疫苗作为控制寄生虫感染的新策略.
- 这项研究为进一步研究rEg.P29疫苗免疫性和保护潜力的研究提供了基础.
更多相关视频
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
8.6K
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
11.7K
相关概念视频
01:29Immune Response Against Viral Pathogens
464
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
464
01:26Antigens Involved in Adaptive Immunity
332
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
332